Ann: IHL Intends to Redomicile to US & List all Shares on Nasdaq, page-522

Dow and NASDAQ up 2 & 1.8%. Good positive moment over the last few days. Yields down 12 basis points, easing inflation now dropping with slowing labour costs and economic outlook easing. Feds holding on hiking interest rate for the year
Might be a perfect storm and good timing for listing.
New investor audience, ASX selling pressure removed, opportunity to buy undervalued heavily manipulated equity on a new platform with possibly 2 drug pathways 42X 675A to acquisition territory in 12-24 months, strong fundamentals, good COH, Clarion cashflow near term with PSI-IND, experienced and we'll renowned team guiding each pathways through regulatory/phase 2-3 trials showing excellent efficiency and safety thus far.
IXHL up 8% during most of trading last night up and 13% in the last 5 trading days. Are the 5-6ct day over.
Great opportunity for the US Investors in the health care space.
GLAH